✦ LIBER ✦

Assessing the cost effectiveness of adjuvant therapies in early breast cancer using a decision analysis model

✍ Scribed by Bruce E. Hillner; Thomas J. Smith; Christopher E. Desch

Publisher: Springer US
Year: 1993
Tongue: English
Weight: 697 KB
Volume: 25
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf00662134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Letrozole in the E

Cost-Effectiveness of Letrozole in the Extended Adjuvant Treatment of Women with Early Breast Cancer

✍ Khalid El Ouagari; Jon Karnon; Thomas Delea; Willena Talbot; Jane Brandman 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 254 KB

The use of aromatase inhibitors in adjuv

The use of aromatase inhibitors in adjuvant therapy for early breast cancer

✍ Walter Jonat; Felix Hilpert; Nicolai Maass 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 250 KB

Cost-effectiveness analysis of trastuzum

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t

Anastrozole is cost-effective vs tamoxif

Anastrozole is cost-effective vs tamoxifen as initial adjuvant therapy in early breast cancer: Canadian perspectives on the ATAC completed-treatment analysis

✍ A. Rocchi; S. Verma 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 158 KB

The impact of tumor progesterone recepto

The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer : A decision analysis

✍ Rinaa S. Punglia; Karen M. Kuntz; Eric P. Winer; Jane C. Weeks; Harold J. Burste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB 👁 1 views

Cost-effectiveness analysis of adjuvant

Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects

✍ Heather-Jane Au; Kamran Golmohammadi; Tallal Younis; Shailendra Verma; Stephen C 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 307 KB